STOCK TITAN

Hims & Hers Health, Inc. to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) will report its Q1 2022 financial results on May 9, 2022, at 4:15 p.m. E.T., followed by a conference call at 5:00 p.m. E.T. Participants can dial +1 (888) 510-2630 for U.S. access or +1 (646) 960-0137 for international access, using conference ID #1704296. A live audio webcast will be available at investors.forhims.com, with a replay accessible for 12 months.

Hims & Hers is a telehealth platform offering diverse healthcare services and can be accessed via a mobile app and retail locations across the U.S. and the U.K.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, will release its first quarter 2022 financial results on Monday, May 9, 2022 at 4:15 p.m. E.T., with a conference call to follow at 5:00 p.m. E.T.

Conference Call Details

The conference call can be accessed by dialing +1 (888) 510-2630 for U.S. participants and +1 (646) 960-0137 for international participants, and referencing conference ID #1704296. A live audio webcast will be available online at https://investors.forhims.com/.

A replay of the call will be available via webcast for on-demand listening for 12 months at the same link.

About Hims & Hers Health, Inc.

Hims & Hers is a multi-specialty telehealth platform transforming the way healthcare is delivered. Its digital platform enables access to treatments for a broad range of conditions, including those related to sexual health, hair loss, dermatology, mental health and primary care. Hims & Hers connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Prescriptions are fulfilled online through licensed pharmacies on a subscription basis, making accessing treatments simple, affordable, and straightforward. Through the Hims & Hers mobile app, consumers can access an ever-expanding range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Hims & Hers products can also be found in tens of thousands of top retail locations in the United States. Launched in November 2017, Hims & Hers serves the entire United States and select locations in the United Kingdom. The company is publicly traded on the New York Stock Exchange. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Investor Relations

Jay Spitzer

+1 (415) 598-0718

Investors@forhims.com

Media Relations

Press@forhims.com

Source: Hims & Hers Health, Inc.

FAQ

When will Hims & Hers announce its Q1 2022 financial results?

Hims & Hers will announce its Q1 2022 financial results on May 9, 2022, at 4:15 p.m. E.T.

How can I access the Hims & Hers conference call?

You can access the Hims & Hers conference call by dialing +1 (888) 510-2630 for U.S. participants or +1 (646) 960-0137 for international participants, using conference ID #1704296.

Is there a way to listen to the Hims & Hers conference call later?

Yes, a replay of the conference call will be available via webcast for on-demand listening for 12 months at investors.forhims.com.

What services does Hims & Hers provide?

Hims & Hers provides a multi-specialty telehealth platform that offers treatments for conditions such as sexual health, hair loss, dermatology, mental health, and primary care.

Hims & Hers Health, Inc.

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Stock Data

5.29B
184.38M
11.39%
66.19%
15.54%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
SAN FRANCISCO